Search Results 641-650 of 11393 for anti-TNF drugs

1. A Study To Evaluate The Accuracy Of The Length-109 Probe Set Panel (A Genetic Test) In Predicting Response To Golimumab In Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   Participation eligibility · biologic therapy targeted at tumor necrosis factor alpha (eg, infliximab, adalimumab, golimumab, etanercept, certolizumab); ...

2. Testing The Addition Of The Drug Atezolizumab To The Usual Radiation Treatment For Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

   Radiation therapy, such as stereotactic body radiation therapy ... agents, corticosteroids or immunosuppressive drugs). ... anti-retroviral therapy, has had at ...

3. Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... In this study, we assessed therapy with anti-TNF agents in patients with TA ...

4. Technetium tc 99m tilmanocept (injection route) - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Clinical trials - Oncology (Medical)

   Testing The Addition Of An Anti-cancer Drug, Selinexor, To The Usual Chemotherapy Treatment (Temozolomide) For Brain Tumors That Have Returned After Previous ...

6. A Study to Evaluate Budesonide in Patients with Immune Mediated Enteropathies - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... anti-TNF monoclonal antibodies, alpha-4 beta-7 ...

7. A Study To Assess The Effectiveness And Safety Of Golimumab In Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   By condition, treatment or drug ... Contraindications to the use of golimumab or infliximab or anti-tumor necrosis factor (TNF-alpha) therapy per local ...

8. Clinical trials - Oncology (Medical)

   Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

9. Chlorpheniramine, ibuprofen, and pseudoephedrine (oral route) - Side effects & dosage - Mayo Clinic

   Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is used in this combination to relieve inflammation, swelling, and pain. This medicine is ...

10. Z-endoxifen shows promise as new treatment for common breast cancer type - Mayo Clinic News Network

    They concluded that, in patients with metastatic breast cancer who had progressed on standard anti-estrogen treatments, Z-endoxifen provides substantial drug ...